Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology

Brain Pathology

Volumn 8, Issue 4, 1998, Pages 681-694

  Storch, Maria K ^a   Stefferl, Andreas ^b   Brehm, Uschi ^b   Weissert, Robert ^c   Wallström, Erik ^c   Kerschensteiner, Martin ^b   Olsson, Tomas ^c   Linington, Chris ^b   Lassmann, Hans ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEMYELINATION; ENCEPHALOMYELITIS; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; MARBURG VIRUS; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; RAT; VIRUS INFECTION;

EID: 0031688565     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00194.x     Document Type: Article

References (44)

1. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, Gardinier MV, Dornmair K, Linington C (1995) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63: 17-27
2. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349-4356
3. Baló J (1928) Encephalitis periaxialis concentrica. Arch Neurol 19: 242-264
4. Barac-Latas V, Suchanek G, Breitschopf H., Stuehler A, Wege H, Lassmann H (1997) Patterns of oligodendroglia pathology in corona virus induced subacute demyelinating encephalomyelitis in the Lewis rat Glia 19: 1-12
5. Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11: 195-199
6. Bonetti B, Raine CS (1997) Multiple sclerosis oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 42 (1): 74-84
7. Charcot JM (1868) Histologie de la sclérose en plaque. Gaz Hôpital (Paris) 41: 554-556
8. Compston A, Sadovnick D (1992) Epidemiology and genetics of multiple sclerosis. Curr Opin Neurol Neurosurg 5: 175-181
9. Dal Canto MC, Rabinowitz SG (1981) Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 11: 109-127
10. Dal Canto MC, Melvold RW, Kim BS, Miller SD (1995) Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 32: 215-229
11. Devic C (1894) Myélite subaigúe compliquée de névrite optique. Bull Med 8: 1033
12. D'Souza SD, Bonetti B, Balasingam V, Cashham NR, Barker PA, Troutt AB, Raine CS, Antel JP (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184: 2361-2370
13. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T et al. (1986) A population-based study of multiple sclerosis in twins. N Eng J Med 315: 1638-1642
14. Ebers GC, Kukay K, Bulman DE, Sadovick AD, Rice G, Anderson C, Armstrong H, Cousin K, Ball RB; Hader W et al. (1996) A full genome search in multiple sclerosis. Nat Genet 13: 472-476
15. Fazarkerley JK, Buchmeier MJ (1993) Pathogenesis of virus-induced demyelination. Adv Virus Res 42: 249-324
16. Gay D, Esiri M (1991) Blood-brain-barrier damage in acute multiple sclerosis plaques. Brain 114: 557-572
17. Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274: 2054-2075
18. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Pencak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A et al. (1996) A genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The multiple sclerosis genetics group. Nat Genet 13: 469-471
19. Hedrich HJ (ed) (1990) Genetic monitoring of inbred strains of rats. Gustav Fischer: Stuttgart/New York
20. Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CCA (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154: 5536-5541
21. Jordan CA, Friedrich VL Jr, Godfraind C, Cardellechio CB, Holmes KV, Dubois-Dalcqu M (1989) Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a corona virus. Glia 2: 318-329
22. Kerlero de Rosbo N, Honegger P, Lassmann H, Matthieu JM (1990) Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendroglia glycoprotein. J Neurochem 55: 583-587
23. Lassmann H (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neurol 25: 1-135
24. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelmating lesions. Acta Neuropathol 75: 566-576
25. Lassmann H (1998) Immunopathology of multiple sclerosis. J Neuroimmunol in press
26. Linington C, Bradt M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443-454
27. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6: 259-274
28. Lumsden CE (1970) The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology, Vinken PI, Bruyn GW (eds), vol 9, pp.217-309, Elsevier: New York
29. Marburg O (1906) Die sogenannte "akute Multiple Sklerose". Jahrb Psychiatrie 27: 211-312
30. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica J Neurol Neurosurg Psychiatry 60 (4): 382-387
31. Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322
32. Piddlesden SJ, Storch MK, Hibbs H, Freemann AM, Lassmann H, Morgan BP (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated allergic encephalomyelitis. J Immunol 52: 5477-5484
33. Prineas JW, Graham JS (1981) Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin break-down. Ann Neurol 10: 149-158
34. Prineas JW (1985) The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology, JC Koetsier (ed), Vol 47, pp 337-395, Elsevier Science
35. Raine CS (1985) Experimental allergic encephalomyelitis and experimental neuritis. In Handbook of Clinical Neurology, JC Koetsier (ed), Vol 47, pp 429-466, Elsevier Science
36. Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58: 39-53
37. Rodriguez M, Prayoonwiwat N, Howe C, Sanborn K (1994) Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis. J Neuropath Exp Neurol 53: 136-143
38. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genomic screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13: 464-468
39. Schilder P (1912) Zur Kenntnis der sogenannten diffusen Sklerose (über Encephalitis periaxialis diffusa). Z Gesamt Neurol Psychiatr 10: 1-60
40. Stone SH, Lerner EM (1965) Chronic disseminated allergic encephalomyelitis in guinea pigs. Ann NY Acad Sci 122: 227-241
41. Storch M, Lassman H (1997) Pathology and pathogenesis of demyelinating diseases. Curr Opin Neurol 10: 186-192
42. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H (1998) Multiple sclerosis: in situ evidence for antibody- and complement mediated demyelination. Ann Neurol 43: 465-471
43. Vass K, Lassmann H, Wekerle H, Wisniewski HM (1986) The distribution of la antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol 70: 149-160
44. Vass K, Heininger K, Schäfer B, Linington C, Lassmann H (1992) Interferon gamma potentiates antibody mediated demyelination in vivo. Ann Neurol 32: 198-206